Introduction
Rheumatoid arthritis (RA) is a progressive, inflammatory disorder, leading to joint degradation and functional impairment. 1 The condition is associated with increased mortality through development of cardiovascular disease (CVD) with accelerated atherosclerosis. 2, 3 Consensus from numerous studies in developed-world populations suggests that the current prevalence of RA is between 0.5% and 2.0% of the adult population, and that this figure has begun to increase in recent years. 2, 4, 5 Risk factors for RA include gender (prevalence of RA female:male, ∼3:1), age (peak incidence at 55-64 years of age for women, 65-74 years of age for men), and smoking. 6 RA has a substantial impact upon patients' quality of life (QOL) as a result of continuous pain, functional disability, reduced mobility and loss of independence in daily life. 7, 8 Increasing pain is associated with a higher degree of depression, even amongst patients who feel their condition to be well controlled. 9 Indeed, much of the patient's burden from RA results from its impact upon the patients' overall sense of well-being; consequently, the use and acceptance of QOL measures in assessing treatment efficacy in RA has become an increasingly important measure of patient health. [10] [11] [12] [13] The five most important outcomes for RA patients are: pain, joint damage, fatigue, activities of daily living and mobility. 14, 15 In addition, patient reported outcomes (PROs) have been shown to be an important indicator for long-term disease progression. 16 The importance of these aspects has recently been emphasized by EULAR (the European League Against Rheumatism) when consideration of patients' perspectives and priorities in treatment decisions was defined as one overarching principle of care for RA patients. 17 While changes in the QOL of RA patients have been studied extensively in clinical trials, relatively little information is available for real-life RA patient populations. Indeed, publications on RA patients have noted that randomized controlled clinical trials do not truly reflect the spectrum of real-life patients encountered in the clinic, for example because their disease activity is lower or higher, they have more/other comorbidities and use more/other concomitant medications. [18] [19] [20] [21] Therefore, analysis of real-life data is of use for comparison with that reported from clinical results and may more accurately reflect the broader patient population, regardless of potentially confounding factors that are typically and necessarily avoided when defining clinical study populations. Here we report the results of a patient questionnaire obtained from members in Lower Saxony, Germany of a patient organization for rheumatic diseases (Rheuma-Liga, RL). As optimal treatment requires a clear understanding of the patients' needs, the aim of this study was to assess patients' QOL as well as their perceived needs and expectations for treatment and support.
Materials and methods

Rheuma-Liga and patient selection
The survey was developed to obtain feedback from the RL members with regard to the extent and nature of their functional impairment and disabilities due to RA, as well as their perception and priorities in terms of their overall RA treatment, and support services provided by RL. The aims of the RL organization are to raise awareness about rheumatic and musculoskeletal diseases (RMDs), improve the QOL for people with RMDs and campaign for the improvement of medical treatment, psychological, and social support.
The RL is an independent organization and has 16 regional sections which comprehensively cover Germany. In total, RL has about 260,000 members and is the largest patient organization in Germany. Between July 1 and August 20, 2009, 3000 of the 55,000 members of RL in Lower Saxony were randomly selected from the member list. A written questionnaire in German language was sent by mail. Patients had the option of returning the completed questionnaire by post or completing the questionnaire online.
Questionnaire structure
The RL questionnaire comprised 40 questions divided into four sections relating to: (1) patient demographics, (2) QOL in RA, (3) treatment expectations, and (4) patient perceptions of RL. The questionnaire, translated into English from the original German, is provided in full in Appendix 1. All responses, including medical histories, and diagnostic and therapeutic information, were provided directly by the respondents without guidance of medical personnel.
Section 1: patient demographics
Questions 1 to 8 recorded patients demographics and medical history including gender, age group, employment status, type of rheumatic condition, severity of rheumatic disease, time since diagnosis and age at time of RA diagnosis.
Section 2: quality of life in RA Questions 9 to 19 related to QOL and were derived from the validated measures Nottingham Health Profile (NHP) 22 and SF-36 Health Survey, 23 although were not validated in the adapted format used; license agreement for use of sections from the SF-36 was obtained from Quality-Metric Inc, (Lincoln, RI, USA). Patients were asked to use subjective scales to assess their impairment.
Briefly, questions 9 to 15 assessed general health, impact of RA on the patients' life and mental health, current QOL, perception of pain, work-related productivity, and social participation. Questions 16 to 18 assessed the patient's ability to perform everyday tasks/activities and the degree of their dependence upon others in their daily lives. Finally, question 19 asked patients to personally rate the importance of specific aspects of daily living.
Section 3: treatment expectations
Questions 20 to 27 related to patients' current treatment and treatment perceptions (assessed using subjective scales).
Questions 20 to 24 recorded what type of medication patients' were currently using, how satisfied they were with submit your manuscript | www.dovepress.com Dovepress Dovepress their current therapy, their degree of involvement in therapy decision making, the efficacy of their current therapy (in terms of maintaining their lifestyle, reducing pain, slowing joint damage, and avoiding disability) and the impact of treatment side-effects on their health/activity.
Question 25 investigated what facets of an "ideal" treatment were rated as most important by patients. These included rapid symptom relief/rapid signs of improvement, persistence of positive results/no loss of efficacy, simplicity of use, absence of side-effects/no injection site skin reaction, low dose/no need for future increase in dose, administration route/ simple to self-administer/no requirement for hospitalization/ can be self-administered without assistance, treatment costs and need only take/administer infrequently. Full details of all questions and subjective response scales can be found in Appendix 1.
Statistics
Descriptive comparisons were used for all individual questionnaire items.
Results
Demographics
In total, 959 of 3000 patients responded to the questionnaire (response rate = 32.0%); of these, 318 (34.3%) had diagnosed RA and were included in this analysis. A detailed summary of patient demographics is presented in Table 1 . The majority of RA patients were female (83.3% vs 16.7% males) and nearly two-thirds (63.5%) of respondents were $60 years old. Most respondents were retired (71.2%). The majority of respondents reported severity of rheumatic disease of either moderate (58.5%) or severe (27.5%), with age at onset most commonly reported as between 40-49 years (29.7%) or 50-59 years (30.1%). 
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Efficacy and tolerability of current treatment
Most respondents (84.0%) rated treatment efficacy as sufficiently effective (ie, improvement) and only 6.8% reported a worsening of their RA under treatment (Table 2) . Consistent with this, 67.3% of respondents were "satisfied" with their current therapy, 22.3% were indifferent ("neither satisfied nor dissatisfied"), and 10.4% were "dissatisfied". In addition, the majority of respondents (61.2%) reported either "none" (17.8%) or "barely noticeable/does not really bother me" (43.4%) side-effects of their current treatment. However, 9.2% of respondents rated side-effects as "occasionally interfering with their daily activities," 3.0% reported side-effects as "frequently interfering with daily activities," and 0.3% recorded that their side-effects were "intolerable".
Involvement of patients in treatment decisions
The overall involvement of respondents in their treatment decisions was unexpectedly low, and 49.6% of respondents felt they were insufficiently involved in decision making by their rheumatologists ("no or little involvement"). In contrast 19.7% reported that they felt "very much" involved.
Patients' priorities for future treatments
More than 80% of respondents considered the following aspects of treatment to be very important for any potential treatment of RA: persistence of positive clinical response for more than one year (92.0%), absence of side-effects (89.2%), no loss of response over time (82.9%), simple to self-administer (82.3%), and no need for hospitalization (80.4%). In addition, the preferred form of treatment administration was a single tablet daily (81.0%), and 85.3% of respondents considered self-administration, without assistance, to be very important.
Patient priorities for QOL
Almost all respondents (97.7%) reported that mobility inside and outside the home was of particular importance to them ( Figure 1 ). Other activities rated to be at least "more or less important" by $90% of respondents included: the ability to run errands/do shopping (97.1%), the ability to undertake housework (95.6%), independence from others (94.2%), and participation in normal social activities with family/friends (93.1%).
Patients' general QOL assessment
For all QOL questions, overall responses from RA patients who reported an additional concomitant rheumatic disease were more negative (worse QOL) than from respondents with RA alone. Overall, 86.9% of respondents rated their general health as either "reasonable" or "good", and 87.6% rated their overall QOL as "reasonable" or "good" (Table 3 ). In contrast, 60.5% of respondents rated the impact of RA upon their lives as "rather bad" or "very bad" (Table 3) .
Pain and physical, or emotional, problems due to RA For 27.6% of respondents, the impact of RA on social activities during the previous month was "strong" to "very strong" (Table 4 ). In addition 49.6% reported their physical impairment in daily work (inside and outside the home) as "rather strongly" to "very strongly" impacted by RA (Table 4) .
Overall, 25.9% of respondents rated their pain over the previous month as "severe" to "very severe" (Table 4 ). Emotional problems due to RA (eg, depression or fear) were experienced regularly (ie, "all the time," "most of the time," or "sometimes") by 59.2% of respondents, "seldom" by 25.5%, and "never/not at all" by 15.3%.
Impact of RA upon daily activities and independence
Most activities of daily living could be performed "without any effort" or "with some effort" by $80% of respondents ( Figure 2 ). Housework was possible "with a lot of effort" for 23.6% of respondents, while 5.2% of respondents reported being "unable" to do housework activities. Driving a car was reportedly not possible for 6.9% of respondents (ie, "unable"). Running errands and shopping was possible only "with a lot of effort" for 17.3% and impossible for 3.3% (ie, "unable").
Restriction in daily activities due to RA was frequently reported ( Figure 3 ). For example: 95.8% of respondents reported restriction in strenuous/exhausting activities (53.7% "very restricted" and 42.1% "somewhat restricted"); 87.9% of respondents reported restriction in lifting/carrying shopping bags (30.2% "very restricted" and 57.7% "somewhat restricted") and 81.1% of respondents reported restriction for moderately strenuous activities such as vacuum cleaning (16.3% "very restricted" and 64.7% "somewhat restricted"). Over 60% of respondents were at least "more or less" dependent upon a third-party in their day-to-day activities, generally upon their partner or family/friends (Table 5 ). In contrast, dependence upon medical personnel was markedly lower, with dependence highest upon "other medical specialist" (excludes "nurse/caregiver") ( Table 5 ).
Assessment of RL
Respondents most commonly learned of RL from other members (39.8%), their rheumatologist (35.6%), or their general practitioner (29.4%). In all 70.6% of respondents took advantage of RL's group physiotherapy program, and in most cases no further individual (ie, one-to-one) physiotherapy was offered by the treating physician. The group physiotherapy program was the most commonly stated (and generally the most important) reason for recommending RL to other respondents (indicated by 86.5% of respondents). Furthermore, over 90% of respondents reported the physiotherapy program improved physical performance and mood, and reduced physical complaints.
Most respondents were aware of RL's different information services, and these were also a common reason for recommending RL to other respondents (68.8%). Overall, .80% of respondents were satisfied with the RL services. The interest in proposed new services was highest for medical support ( for courses about diet and rheumatism (88.6%), and back training (84.0%).
Discussion
This study was designed to provide a clearer understanding of patient priorities and needs amongst the members of an arthritis patient organization. For this purpose, a questionnaire was developed to obtain insight into patients' needs, their functional limitations and other disease associated aspects. It was not the intention to develop a new QOL assessment for RA respondents. The resulting survey was relatively long (40 questions) and was sent to a randomly selected group of RL members who were asked to complete and return the questionnaire. Even though nearly one third of those invited did participate in the survey, the opinions obtained may reflect a selection of the most active or motivated members. This paper addresses only the results from those 34% of respondents who reported a diagnosis of RA, which may also limit conclusions.
As the survey used a non-validated questionnaire the responses were not calibrated to any clinical metric, therefore data could not be normalized against any other patient or healthy population responses and no domain-style summary analyses were possible. Data summaries and comparison were further limited by the lack of common scales between questions/sections. The results must therefore be considered on a subjective, question-by-question basis, and cannot be realistically assessed in a broader context. In addition, the participating population reflected the local RL membership and differed from observed broader RA populations; submit your manuscript | www.dovepress.com
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for example, in gender ratio female:male (5:1 vs 2-3:1 expected), a median age . 60 years, and a median time since diagnosis . 10 years. 6 As such, males, as well as younger patients and those patients with shorter disease durations, were under-represented. 24, 25 While this survey has provided important insight into specific RA patient issues, use of a validated assessment would have resulted in more representative data. For example, use of Short Form-36 (SF-36), 23 which is known to be sensitive to clinically relevant signals in RA populations, 13 or the SF-12 (a subset of the SF-36 questions), would improve the clinical relevance of the results of this survey. However, the questionnaire was designed to capture different aspects of the disease, including its burden and treatment aspects, as well as information about the performance of RL services. To include these domains, the questionnaire developed was felt to be the most practical way, even though this resulted in some limitations.
Despite these limitations, certain patterns were clear in the responses. In common with many QOL surveys of RA, 7, 26 participants stated that RA reduced their QOL and caused impairment in daily activities, including restricting their independence and mobility. Indeed, well over half the respondents were dependent upon a third party. Almost unanimously, respondents stated mobility and independence from other people were important to them. The burden of care fell largely upon family and friends rather than medical personnel, likely concealing much of the resulting cost burden.
Current guidelines from EULAR state that "best care" includes explicit patient involvement in treatment decisions. 17 It was surprising then, that despite being satisfied with the clinical efficacy of their treatment approximately half of all respondents felt they were insufficiently involved in the clinical decision making process -which directly contradicts current best care guidelines. Increased patient involvement in decision making processes is important in improving patient´s empowerment and may enhance treatment outcomes. 27, 28 While on the other hand, a lack of patient-doctor communication regarding RA treatment decisions is associated with increased incidence of moderate to severe depression. 29 One possible limiting factor to full application of the concept of shared decision in the German clinic is the tight schedule for individual patient visits. This could be improved by increasing the number of physicians, introducing structured patient information and increasing involvement of assistants and nurses. 30 With the development of therapeutic options like biologic agents rheumatologists acknowledge the need to involve the patients in the treatment decisions, as this has been shown to improve their adherence to therapy. 31 Another driver to implement the concept of shared decision making could be the fact that patient participation is increasingly seen as a quality indicator for medical care within the German health care system. 32 The survey results presented here also served to underline the importance of patient support groups, such as RL, as providers of services beneficial for patient health and QOL, such as physiotherapy (not otherwise provided through their physician) and of information on coping with their disease. These services empower patients and help them maximize their independence. In this survey, group physiotherapy was considered important to many respondents and was felt to improve their physical and mental health. It was also of note that assistance in communicating with medical staff (seeking second opinions) and dealing with health insurance companies were amongst the most strongly requested new services from RL. Taken together with the low patient involvement in clinical decisions, this suggests professional support services are still failing to fully engage this patient population, indicating a clear need for greater dialogue between patients (or patient organizations), physicians, and cost carriers/health care services.
Patient priorities of the assessed population were clearly focused on independence, but it remains to be investigated if a younger population would give a substantially different response in this regard. In addition, it may be that those who responded were different in important respects from non-responders, thus limiting the general applicability of the findings. Feedback from patients using the online version of the questionnaire was very poor, which may also suggest response was obtained from a subset population.
In summary, RA imposes a substantial physical and emotional burden upon patients. The highest priorities for patients, however, are mobility, independence, and coping with everyday activities. Physiotherapy and information services help patients cope with their condition day-to-day, and are primarily provided by patient support organizations such as RL. While generally satisfied with their treatment efficacy, patients may benefit from greater involvement in treatment decisions. 
